JPRN-UMIN000000959已完成1 期
Combination therapy of the peptide vaccines and dexamethasone for hormone-refractory prostate cancer: Early phase II randomized controlled study - Combination therapy of the peptide vaccines and dexamethasone for hormone-refractory prostate cancer
Department of Urology, Kinki University School of Medicine0 个研究点目标入组 100 人开始时间: 2008年1月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Any patient who falls under any of the following criteria is excluded as a candidate: 1.Patients who have any severe underlying medical condition such as severe active infection, cardiovascular disease, respiratory disease, renal dysfunction, immune dysfunction, blood coagulation disorder and so on. 2.Active double cancer. 3.Past history of severe allergic disease. 4.Patients previously treated with an adrenocortical steroid such as dexamethasone. Temporary use of a steroid against a non-prostate cancer related diseases, for example allergies, are not excluded. 5.Patients previously treated with systemic chemotherapy including Docetaxel and Cisplatin or radiotherapy against non-primary disease. 6. Hepatitis type B or C should be excluded. 7. Any patients disqualified by a study physician.
研究者
相似试验
进行中（未招募）
不适用
Peptide-based vaccine in combination or not with chemotherapy in melanoma patients: a phase II randomized clinical study. - NDMedDRA version: 12.0Level: HLTClassification code 10027156Term: Skin melanomas (excl ocular)advanced melanomaEUCTR2008-008211-26-ITISTITUTO SUPERIORE DI SANITA`
已完成
1 期
Treatment with cancer peptide vaccine cocktail derived from URLC10, KIF20A, VEGFR-1 and VEGFR-2 for the patients with advanced or recurrent esophageal cancer refractory to the standerd tharapyEsophageal cancerJPRN-UMIN000013709Wakayama Medical University40
尚未招募
不适用
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)on Small Cell Lung CancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000270Center of Molecular Immunology (CIM)30
已完成
1 期
Cancer peptide vaccine therapy for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.Colorectal cancerJPRN-UMIN000004945Tokai University School of Medicine20
招募中
不适用
Immunization with peptide-mix and adjuvant. A vaccine to induce cellular immunity against HIV-1 [retrospectively registered]HIV/AIDSPACTR201110000274327Statens Serum Institut (Helle Bossen Konradsen)20